Bora Pharmaceuticals Co., LTD. (TPE:6472)

Market Cap	90.97B
Revenue (ttm)	21.32B
Net Income (ttm)	4.15B
Shares Out	124.10M
EPS (ttm)	31.04
PE Ratio	19.26
Forward PE	18.94
Dividend	11.67 (1.59%)
Ex-Dividend Date	Jun 20, 2025

Volume	457,830
Average Volume	1,019,964
Open	739.00
Previous Close	736.00
Day's Range	730.00 - 740.00
52-Week Range	468.72 - 795.00
Beta	0.77
RSI	52.03
Earnings Date	Aug 11, 2025

About TPE:6472

Bora Pharmaceuticals Co., LTD. engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally. The company operates through Sales, CDMO, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services and technical services for the development of pharmaceutical products. In addition, it provides Western pharmaceuticals, including central nervous system medications, antibioti...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2007
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 6472

Financial Performance

In 2024, TPE:6472's revenue was 19.25 billion, an increase of 35.53% compared to the previous year's 14.20 billion. Earnings were 3.94 billion, an increase of 29.99%.